Immunogenicity after heterologous third dose COVID‐19 vaccination in a heart transplant recipient
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Transplantation"
DOI: 10.1111/ctr.14605
Abstract: COVID-19 vaccines utilizing mRNA technology induce vigorous immuneresponsesandexcellentprotectionagainstdiseaseinimmuno-competentadults. 1 Thedegreeofvaccineefficacyintransplantedindi-viduals remains unknown. Recent studies demonstrated the standard two-dose regimen of the Pfizer-BioNTech BNT162b2 vaccine could yield suboptimal immune responses and incomplete clinical protection in transplanted… read more here.
Keywords: vaccination; transplant recipient; immunogenicity heterologous; dose covid ... See more keywords
Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19—BNT162b2 mRNA Vaccination
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14071470
Abstract: (1) Background: High immunosuppressive regimen in lung transplant recipients (LTRs) hampers the immune response to vaccination. We prospectively investigated the immunogenicity of heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA vaccination in an LTR cohort. (2) Methods: Forty-nine COVID-19… read more here.
Keywords: lung transplant; chadox1 ncov; vaccination; immunogenicity heterologous ... See more keywords